Duodenal ulcer healing and relief of symptoms during treatment with omeprazole 20 or 40 mg once daily for 2-8 weeks (Study I-900a). Prevention of duodenal ulcer relapse during maintenance treatment with omeprazole 10 mg once daily, omeprazole 20 mg once daily, or ranitidine 150 mg for twelve months (Study I-900b)
Study identifier:I-900
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
Duodenal ulcer healing and relief of symptoms during treatment with omeprazole 20 or 40 mg once daily for 2-8 weeks (Study I-900a). Prevention of duodenal ulcer relapse during maintenance treatment with omeprazole 10 mg once daily, omeprazole 20 mg once daily, or ranitidine 150 mg for twelve months (Study I-900b)
Medical condition
Acid Reflux
Phase
N/A
Healthy volunteers
-
Study drug
-
Sex
-
Actual Enrollment
-
Study type
Interventional
Age
-
Date
Study Start Date: 01 Jan 1971
Primary Completion Date: -
Study Completion Date: -
Study design
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verification:
Verified 01 Nov 2013 by AstraZeneca
Sponsors
AstraZeneca
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|
